Utilizing HCC clinical samples, animal models and cell lines, this study innovatively elucidated the mechanism by which STT3A-mediated N-glycosylation of FCN3 promoted HCC progression through Wnt/β-catenin-dependent Treg cell activation. The gene discussed is FCN3; the disease is hepatocellular carcinoma.